Abstract DA41 was previously identified as one of the DAN-binding proteins, via a yeast-based two-hybrid screening strategy. In the present study, we cloned a human homolog of DA41 cDNA. Structural analysis revealed that human DA41 cDNA consisted of 2,861 nucleotides in length and encoded a protein of 589 amino acids, with a predicted molecular mass of 62.4 kDa. Human DA41 exhibited an 86% amino acid sequence identity to rat DA41, indicating the evolutionarily conserved structure and function of DA41. A database search for DA41-related protein(s) identified mouse PLIC-1, PLIC-2, frog XDRP1, and yeast DSK2. DA41 and each DA41-related protein contain a ubiquitin-like domain in their amino-terminal regions. DA41 was expressed ubiquitously in adult human tissues, with relatively higher levels in pituitary gland, adrenal gland, kidney, thymus, and placenta. Fluorescence in situ hybridization (FISH) revealed that DA41 was mapped to human chromosome 9q21.2-q21.3, a position overlapping the candidate tumor suppressor locus for bladder cancer.
Introduction
The DAN gene was originally cloned as one of the genes whose expression was significantly reduced in rat fibroblast 3Y1 cells transformed with Rous sarcoma virus (SR-3Y1) (Ozaki and Sakiyama 1993) . The expression of DAN was also downregulated in rodent fibroblasts transformed with a variety of oncogenes (Ozaki and Sakiyama 1993; Ozaki et al. 1996) . Overexpression of DAN in SR-3Y1 cells markedly suppressed the transformed phenotypes of the recipient cells, indicating the growth-and tumor-suppressive properties of DAN protein (Ozaki and Sakiyama 1994) . Interestingly, DAN is a secreted glycoprotein (Nakamura et al. 1997; Stanley et al. 1998 ) and possesses a characteristic cysteineknot structure common to the DAN/Cerberus family, which includes Gremlin/Drm (Hsu et al. 1998) . Like DAN, the expression of Drm was significantly decreased in various transformed cells and its gene product showed a growthsuppressive activity in vitro (Topol et al. 1997) . Recently, Hsu et al. (1998) demonstrated that the DAN/Cerberus family can interact with BMP2 and block BMP2 signalling in Xenopus early embryos. Similar results were also obtained in mammalian cell systems (Pearce et al. 1999) .
DA41 was initially identified as a new cellular protein which can associate with DAN, in a study that used a yeast two-hybrid screening of an adult rat lung cDNA library . The interaction between DAN and DA41 was mediated through the amino-terminal domain and the cysteine-knot region of DAN. The expression of DA41 was regulated in a cell cycle-dependent manner. In the present study, we performed cDNA cloning and characterization of human DA41, including its expression and its chromosomal mapping.
Methods, results, and discussion
In order to isolate a full-length human homolog of DA41 cDNA, we screened a human nigra cDNA library (approximately 5 ϫ 10 6 independent phage clones), using a radio-labeled full-length rat DA41 cDNA as a probe. Among seven positives, we picked up two independent clones (λ41-7 and λ41-9) which harbored the longer cDNA inserts. Because the putative initiation codon was not located within the nucleotide sequences of these cDNA clones, the 5Ј-region of DA41-7 cDNA was radiolabeled and used to screen a human lung cDNA library (approximately 5 ϫ 10 6 recombinants). This screening yielded four independent positive signals. Sequence analysis revealed that the clone λ41-11 contained a possible initiation codon (at position ϩ1), which fulfilled Kozak's criteria for an initiation codon (Kozak 1987) , and was preceded by an in-frame stop codon at position Ϫ30. The assembled human DA41 cDNA consisted of 2,861 nucleotides and contained a single open reading frame of 1,767 nucleotides. The 3Ј-untranslated region (UTR) contained a consensus polyadenylation signal AATAAA at position ϩ2,111 and a poly(A) sequence at the end (Fig. 1) . The DA41 gene possibly exists as a single copy in the human genome, as examined by genomic Southern analysis (data not shown). Human DA41 encoded a protein consisting of 589 amino acid residues with a predicted molecular mass of 62.4kDa. Human DA41 exhibited 86% identity to rat DA41 at the protein level (Fig. 2) . A recent database search for DA41-related protein(s) identified mouse PLIC-1 and PLIC-2 (Wu et al. 1999) , frog XDRP1 (Funakoshi et al. 1999) , and yeast DSK2 (Biggins et al. 1996) . PLIC-1 and PLIC-2 are closely related in sequence (higher than 80% sequence identity between them). Human DA41 exhibited 81%, 61%, 57%, and 20% amino acid sequence identity to PLIC-1, PLIC-2, XDRP1, and DSK2, respectively (Fig. 2) . PLIC-1 and PLIC-2 were identified to The amino acid sequence alignment of human DA41 with rat DA41 (accession no. D87950) and the other previously reported DA41-related proteins; mouse PLIC-1 (accession no. AF177345), mouse PLIC-2 (accession no. AF177346), frog XDRP1 (accession no. AB030502), and yeast DSK2 (accession no. L40587). Identical amino acid residues are printed in white type on black background. Gaps are introduced to maximize the alignment. N-terminal UBQ and Cterminal UBA regions are underlined interact with the cytoplasmic tail of integrin-associated protein (IAP) and mediated the interaction between IAP and vimentin-containing intermediate filaments (Wu et al. 1999) . XDRP1 was associated with the amino-terminal region of cyclin A and inhibited the degradation of cyclin A (Funakoshi et al. 1999 ). Overproduction of DSK2 induced a mitotic defect with short spindle (Biggins et al. 1996) . DA41 and each DA41-related protein share evolutionarily conserved amino-terminal and carboxy-terminal regions which are homologous to ubiquitin (UBQ domain) and ubiquitinassociated region (UBA domain), respectively (Wu et al. 1999) . Human DA41 was 94%, 88%, 58%, and 37% identical to the UBQ domains of PLIC-1, PLIC-2, XDRP1, and DSK2, respectively. Similarly, human DA41 exhibited 96%, 98%, 91%, and 38% sequence identity to the UBA domains of PLIC-1, PLIC-2, XDRP1, and DSK2, respectively.
We analyzed the expression of the human DA41 gene in adult tissues. Human RNA master blot (Clontech, Palo Alto, CA, USA) was hybridized under the conditions recommended by a manufacturer. A random primer-labeled 3Ј-untranslated region of human DA41 cDNA was used as a probe in this experiment. As shown in Fig. 3a , human RNA master blot analysis revealed the ubiquitous expression of the DA41 gene. Abundant expression was detected in adult pituitary gland, adrenal gland, kidney, thymus, and placenta. Ubiquitous expression of the DA41 gene was also observed in adult rat tissues . Similarly, PLIC-1 and PLIC-2 were expressed in most mouse tissues and cell types (Wu et al. 1999) .
In order to determine the chromosomal location of DA41, a human PAC library was screened with PCR, using primers specific for DA41 (5Ј-ACTGCATGCATCACT-TCTGC-3Ј) and (5Ј-TGGACAGATGCAGGACAAAA-3Ј). A single PAC clone, which was confirmed to contain DA41 by Southern blot hybridization, was obtained. This PAC clone was then labeled with biotin and used for direct R-banding fluorescence in situ hybridization (FISH) (Takahashi et al. 1990 (Takahashi et al. , 1991 . As shown in Fig. 3b , twin signals were observed on the q21.2-q21.3 band of chromosome 9. Funakoshi et al. (1999) have found that frog XDRP1, which exhibits extensive homology with DA41, can associate with cyclin A-CDK complex. Overproduction of XDRP1 inhibited the degradation of cyclin A and blocked cell division. These observations strongly suggest that DA41 and XDRP1 could share a similar function in cell cycle regulation. It is intriguing to note that the expression of DA41 was regulated in a cell cycle-dependent manner in synchronized 3Y1 rat fibroblasts . Recently, two candidate tumor suppressor loci for bladder cancer were identified on chromosome 9; 9p21-q21 and distal chromosome 9q (Simoneau et al. 1996) . In addition, the proximal region of chromosome 9q was deleted in bladder cancer (Bernues et al. 1993) . Because DA41 was mapped within or near the candidate locus for bladder cancer, DA41 may be involved in bladder carcinogenesis. To test this possibility, information on structural alteration(s) within DA41 in primary bladder cancers is necessary.
